Kuo‐Hsuan Chang

5.4k total citations · 1 hit paper
171 papers, 4.0k citations indexed

About

Kuo‐Hsuan Chang is a scholar working on Neurology, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kuo‐Hsuan Chang has authored 171 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 66 papers in Neurology, 56 papers in Molecular Biology and 55 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kuo‐Hsuan Chang's work include Parkinson's Disease Mechanisms and Treatments (28 papers), Genetic Neurodegenerative Diseases (25 papers) and Alzheimer's disease research and treatments (21 papers). Kuo‐Hsuan Chang is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (28 papers), Genetic Neurodegenerative Diseases (25 papers) and Alzheimer's disease research and treatments (21 papers). Kuo‐Hsuan Chang collaborates with scholars based in Taiwan, United States and United Kingdom. Kuo‐Hsuan Chang's co-authors include Chiung‐Mei Chen, Yih‐Ru Wu, Jeffrey L. Saver, Meng Lee, Guey‐Jen Lee‐Chen, Bruce Ovbiagele, Long‐Sun Ro, Hung‐Wei Liao, Soju Chang and Rong‐Kuo Lyu and has published in prestigious journals such as Advanced Materials, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kuo‐Hsuan Chang

165 papers receiving 4.0k citations

Hit Papers

Biomarker of Neuroinflamm... 2022 2026 2023 2024 2022 50 100 150

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kuo‐Hsuan Chang Taiwan 32 1.4k 1.1k 764 645 527 171 4.0k
Sung‐Chun Tang Taiwan 43 1.6k 1.2× 1.4k 1.3× 565 0.7× 902 1.4× 1.4k 2.6× 251 6.9k
Na Zhao China 31 1.8k 1.3× 494 0.5× 612 0.8× 1.8k 2.9× 233 0.4× 139 4.9k
Irene Paterniti Italy 44 1.9k 1.4× 550 0.5× 477 0.6× 733 1.1× 396 0.8× 191 5.1k
Keri L.H. Carpenter United Kingdom 43 1.8k 1.3× 2.2k 2.0× 429 0.6× 265 0.4× 956 1.8× 113 5.3k
Iain P. Hargreaves United Kingdom 35 3.2k 2.3× 464 0.4× 472 0.6× 775 1.2× 697 1.3× 112 5.0k
Gang Zhao China 39 2.1k 1.5× 426 0.4× 200 0.3× 420 0.7× 378 0.7× 134 4.8k
Yong Wei China 22 1.7k 1.2× 319 0.3× 330 0.4× 936 1.5× 401 0.8× 56 3.9k
Fan Fan United States 35 1.4k 1.0× 247 0.2× 244 0.3× 753 1.2× 354 0.7× 176 4.2k
Xinbing Wei China 39 2.0k 1.4× 350 0.3× 257 0.3× 417 0.6× 409 0.8× 72 4.0k
Earl F. Ellis United States 34 1.3k 0.9× 1.0k 0.9× 797 1.0× 599 0.9× 493 0.9× 62 3.8k

Countries citing papers authored by Kuo‐Hsuan Chang

Since Specialization
Citations

This map shows the geographic impact of Kuo‐Hsuan Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kuo‐Hsuan Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kuo‐Hsuan Chang more than expected).

Fields of papers citing papers by Kuo‐Hsuan Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kuo‐Hsuan Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kuo‐Hsuan Chang. The network helps show where Kuo‐Hsuan Chang may publish in the future.

Co-authorship network of co-authors of Kuo‐Hsuan Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Kuo‐Hsuan Chang. A scholar is included among the top collaborators of Kuo‐Hsuan Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kuo‐Hsuan Chang. Kuo‐Hsuan Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Chang, Kuo‐Hsuan, et al.. (2024). Diagnostic Potential of Alternations of Bile Acid Profiles in the Plasma of Patients with Huntington’s Disease. Metabolites. 14(7). 394–394. 1 indexed citations
3.
Lin, Te‐Hsien, I‐Cheng Chen, Chih‐Hsin Lin, et al.. (2024). Small Molecules Inducing Autophagic Degradation of Expanded Polyglutamine Protein through Interaction with Both Mutant ATXN3 and LC3. International Journal of Molecular Sciences. 25(19). 10707–10707. 1 indexed citations
4.
Chang, Chien-Hung, et al.. (2024). Predictive modelling of hospital-acquired infection in acute ischemic stroke using machine learning. Scientific Reports. 14(1). 31066–31066.
5.
Chen, Chiung‐Mei, et al.. (2023). A Neuroprotective Action of Quercetin and Apigenin through Inhibiting Aggregation of Aβ and Activation of TRKB Signaling in a Cellular Experiment. Biomolecules & Therapeutics. 31(3). 285–297. 28 indexed citations
6.
Chang, Kuo‐Hsuan, Chia-Hsin Liu, Yiru Wang, et al.. (2023). Upregulation of APAF1 and CSF1R in Peripheral Blood Mononuclear Cells of Parkinson’s Disease. International Journal of Molecular Sciences. 24(8). 7095–7095. 2 indexed citations
7.
Lin, Chih‐Hsin, Chung‐Yin Lin, Yen‐Shi Lo, et al.. (2023). Investigating Therapeutic Effects of Indole Derivatives Targeting Inflammation and Oxidative Stress in Neurotoxin-Induced Cell and Mouse Models of Parkinson’s Disease. International Journal of Molecular Sciences. 24(3). 2642–2642. 18 indexed citations
8.
Wu, Yih‐Ru, Yang‐Yu Cheng, Chien‐Tai Ren, et al.. (2023). Ganglioside-focused Glycan Array Reveals Abnormal Anti-GD1b Auto-antibody in Plasma of Preclinical Huntington’s Disease. Molecular Neurobiology. 60(7). 3873–3882. 1 indexed citations
9.
Chang, Kuo‐Hsuan, Chiung‐Mei Chen, Chia‐Ni Lin, et al.. (2023). Identification of blood metabolic biomarkers associated with diabetic distal symmetric sensorimotor polyneuropathy in patients with type 2 diabetes mellitus. Journal of the Peripheral Nervous System. 28(4). 651–663. 3 indexed citations
10.
Chang, Kuo‐Hsuan, Mei‐Ling Cheng, Hsiang-Yu Tang, et al.. (2022). Alterations of Sphingolipid and Phospholipid Pathways and Ornithine Level in the Plasma as Biomarkers of Parkinson’s Disease. Cells. 11(3). 395–395. 27 indexed citations
11.
Lee, Cheng‐Hung, Julien G. Roth, Ching‐Chi Chiu, et al.. (2022). Tuning pro-survival effects of human induced pluripotent stem cell-derived exosomes using elastin-like polypeptides. Biomaterials. 291. 121864–121864. 7 indexed citations
12.
Lin, Te‐Hsien, Chiung‐Mei Chen, Chih‐Hsin Lin, et al.. (2021). Novel Synthetic Coumarin‐Chalcone Derivative (E)‐3‐(3‐(4‐(Dimethylamino)Phenyl)Acryloyl)‐4‐Hydroxy‐2H‐Chromen‐2‐One Activates CREB‐Mediated Neuroprotection in Aβ and Tau Cell Models of Alzheimer’s Disease. Oxidative Medicine and Cellular Longevity. 2021(1). 3058861–3058861. 14 indexed citations
13.
Chen, Chiung‐Mei, Te‐Hsien Lin, Shu-Mei Yang, et al.. (2020). New Synthetic 3-Benzoyl-5-Hydroxy-2H-Chromen-2-One (LM-031) Inhibits Polyglutamine Aggregation and Promotes Neurite Outgrowth through Enhancement of CREB, NRF2, and Reduction of AMPKα in SCA17 Cell Models. Oxidative Medicine and Cellular Longevity. 2020. 1–17. 5 indexed citations
14.
Ng, Chau Yee, et al.. (2020). Association of multiple sclerosis with vitiligo: a systematic review and meta-analysis. Scientific Reports. 10(1). 17792–17792. 4 indexed citations
15.
Lin, Te‐Hsien, Chih‐Hsin Lin, Chung‐Yin Lin, et al.. (2020). Exploration of multi‐target effects of 3‐benzoyl‐5‐hydroxychromen‐2‐one in Alzheimer’s disease cell and mouse models. Aging Cell. 19(7). e13169–e13169. 14 indexed citations
16.
Wu, Yi-Ming, Chi‐Hung Liu, Kuo‐Hsuan Chang, et al.. (2020). Computed Tomography Angiography in Acute Stroke Patients Receiving Recombinant Tissue Plasminogen Activator: Outcome and Safety Evaluations in an Asian Population. Cerebrovascular Diseases. 49(1). 62–69. 4 indexed citations
17.
Chen, I‐Cheng, Te‐Hsien Lin, Chih‐Ying Chao, et al.. (2018). Formulated Chinese Medicine Shaoyao Gancao Tang Reduces Tau Aggregation and Exerts Neuroprotection through Anti‐Oxidation and Anti‐Inflammation. Oxidative Medicine and Cellular Longevity. 2018(1). 9595741–9595741. 31 indexed citations
18.
Chen, Chiung‐Mei, et al.. (2018). Novel synthetic chalcone‐coumarin hybrid for Aβ aggregation reduction, antioxidation, and neuroprotection. CNS Neuroscience & Therapeutics. 24(12). 1286–1298. 49 indexed citations
19.
Chen, Chiung‐Mei, Yu‐Ting Weng, Wan-Ling Chen, et al.. (2014). Aqueous extract of Glycyrrhiza inflata inhibits aggregation by upregulating PPARGC1A and NFE2L2–ARE pathways in cell models of spinocerebellar ataxia 3. Free Radical Biology and Medicine. 71. 339–350. 37 indexed citations
20.
Wang, Chun-Kai, et al.. (2006). α-Synuclein promoter RsaI T-to-C polymorphism and the risk of Parkinson’s disease. Journal of Neural Transmission. 113(10). 1425–1433. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026